Yousif Capital Management LLC Has $31.21 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Yousif Capital Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 100,032 shares of the healthcare conglomerate’s stock after selling 1,770 shares during the quarter. Yousif Capital Management LLC’s holdings in UnitedHealth Group were worth $31,207,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in UNH. Brighton Jones LLC boosted its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the period. GAMMA Investing LLC lifted its stake in shares of UnitedHealth Group by 7.4% in the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock worth $8,295,000 after acquiring an additional 1,089 shares during the period. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the first quarter worth approximately $42,000. Finally, Missouri Trust & Investment Co lifted its stake in shares of UnitedHealth Group by 8.8% in the first quarter. Missouri Trust & Investment Co now owns 4,204 shares of the healthcare conglomerate’s stock worth $2,202,000 after acquiring an additional 340 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. Piper Sandler cut their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Sanford C. Bernstein lifted their target price on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Bank of America lifted their target price on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Trading Down 3.6%

NYSE UNH opened at $354.30 on Monday. The company has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a P/E/G ratio of 2.29 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The business has a 50 day moving average price of $318.21 and a 200-day moving average price of $348.08. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.